bioMérieux’s Margin Masterplan — How Is the GO.28 Initiative Powering Profit Growth? 

bioMérieux’s first half of 2025 financial results present a mixed bag of performance indicators that provide a complex picture for potential investors. On the positive side, the company reported a robust 9.4% organic sales growth, largely driven by double-digit expansions in key growth areas, including respiratory panels and nonrespiratory panels under the BIOFIRE brand. This expansion was complemented by significant strides in profitability, with a 24% increase in like-for-like operating profit, culminating in an 18.2% profit margin compared to 16.4% at the end of 2023. Additionally, the strong performance in the North American and Latin American markets, which saw organic growth rates of 15% and 17%, respectively, highlights bioMérieux’s expanding footprint and market penetration.